HLA-B57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B57:01-negative subjects

被引：0

作者：

Catherine Butkus Small

David A. Margolis

Mark S. Shaefer

Lisa L. Ross

机构：

[1] Weill Cornell Medical College,

[2] New York Medical College,undefined

[3] ViiV Healthcare,undefined

来源：

BMC Infectious Diseases | / 17卷

关键词：

Abacavir; Lamivudine; Hypersensitivity; HLA-B*57:01; HIV infection;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study
Karam Mounzer
Ricky Hsu
Jennifer S. Fusco
Laurence Brunet
Cassidy E. Henegar
Vani Vannappagari
Chris M. Stainsby
Mark S. Shaefer
Leigh Ragone
Gregory P. Fusco
AIDS Research and Therapy, 16
[42] HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study
Mounzer, Karam
Hsu, Ricky
Fusco, Jennifer S.
Brunet, Laurence
Henegar, Cassidy E.
Vannappagari, Vani
Stainsby, Chris M.
Shaefer, Mark S.
Ragone, Leigh
Fusco, Gregory P.
AIDS RESEARCH AND THERAPY, 2019, 16
[43] Hla-b☆5701 allele is the leading marker of hypersensitivity reactions for abacavir-including therapy in hiv-infected patients
Begaidarova, R. H.
Sagimbaev, B. Zh
Devdariani, Ch. G.
Alshynbekova, G. K.
Yukhnevich-Nassonova, Y. A.
ALLERGY, ASTHMA & IMMUNOPHYSIOLOGY: RECENT ADVANCES IN UNDERSTANDING AND MANAGEMENT, 2015, : 91 - 92
[44] Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan
Sun, Hsin-Yun
Hung, Chien-Ching
Lin, Pi-Han
Chang, Shu-Fang
Yang, Ching-Yao
Chang, Sui-Yuan
Chang, Shan-Chwen
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (03) : 599 - 604
[45] STUDY OF VARIOUS METHODS FOR DETECTING HLA-B*57:01 ALLELE IN PLHIV IN EASTERN UP, INDIA.
Rai, T. K.
Srivastav, S.
Chakravarty, J.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S33 - S33
[46] CD4+ T cells prevent abacavir hypersensitivity reactions in HLA-B*57:01 transgenic mice
Cardone, Marco
Garcia, Karla
Yano, Masahide
Mattson, Elliot
Juengst, Leslie
Roderiquez, Gregory
Tilahun, Mulualem E.
Boyd, Lisa F.
Natarajan, Kannan
Puig, Montserrat
Margulies, David H.
Norcross, Michael A.
JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
[47] Prevalence of Human Leukocyte Antigen (HLA)-B*57:01 in HIV-Infected Patients
Deveci, Aydin
Coban, Ahmet Yilmaz
Durupinar, Belma
MIKROBIYOLOJI BULTENI, 2016, 50 (04): : 544 - 551
[48] HIV Minor Variants Detected by Next Generation Sequencing: Impact on Immune Control of HIV in the Context of HLA-B*27:05 and HLA-B*57:01
Brener, Jacqui
Gall, Astrid
Batorsky, Rebecca
Kellam, Paul
Allen, Todd
Matthews, Philippa
Goulder, Philip
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A180 - A181
[49] Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa
Malewe Kolou
Armel Poda
Zelica Diallo
Esther Konou
Tatiana Dokpomiwa
Jacques Zoungrana
Mounerou Salou
Lionèle Mba-Tchounga
André Bigot
Abdoul-Salam Ouedraogo
Marielle Bouyout-Akoutet
Didier K. Ekouevi
Serge P. Eholie
BMC Immunology, 22
[50] Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa
Kolou, Malewe
Poda, Armel
Diallo, Zelica
Konou, Esther
Dokpomiwa, Tatiana
Zoungrana, Jacques
Salou, Mounerou
Mba-Tchounga, Lionele
Bigot, Andre
Ouedraogo, Abdoul-Salam
Bouyout-Akoutet, Marielle
Ekouevi, Didier K.
Eholie, Serge P.
BMC IMMUNOLOGY, 2021, 22 (01)

← 1 2 3 4 5 →

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects

HLA-B57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B57:01-negative subjects